Citation Impact
Citing Papers
Antidepressant Drug Effects and Depression Severity
2010 Standout
Breast cancer
2019 Standout
Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract
2011
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
2008
An Overview of Psychotropic Drug-Drug Interactions
2005
Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study
2017
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Exenatide
2007
Comparison of Duloxetine, Escitalopram, and Sertraline Effects on Cytochrome P450 2D6 Function in Healthy Volunteers
2007
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients
2009
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Osteoarthritis
2019 Standout
Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers
2004
Glycaemic control in type 2 diabetes: Targets and new therapies
2009
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
2008
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: effect of temperature on synthesis, anti-bacterial activity and anti-diabetic activity
2014 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Depression and coronary artery disease: the association, mechanisms, and therapeutic implications.
2009
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
2010
Exenatide
2007
Works of Maggie Lim being referenced
Effect of Exenatide on the Steady‐State Pharmacokinetics of Digoxin
2005
Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects
2006
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers
2003